Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004
Clinical trial NCT06813781 · COMPLETED
Trial details
- NCT number
- NCT06813781
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2025-10-02
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.